CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-01 | Seshadri Vishwas SVP, Head of Res./Clin. Dev. | Grant or award | +200,000 | 200,000 | ||
| 2021-06-01 | Seshadri Vishwas SVP, Head of Res./Clin. Dev. | Grant or award | +100,000 | 300,000 | ||
| 2021-06-01 | Seshadri Vishwas SVP, Head of Res./Clin. Dev. | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2021-05-25 | Wuchterl Donald A. Director | Grant or award | +77,181 | 77,181 | ||
| 2021-05-25 | Wuchterl Donald A. Director | Grant or award · Stock Option (right to buy) | +98,168 | 98,168 | ||
| 2021-05-25 | Mann Paul Elliot Director | Grant or award | +38,590 | 38,590 | ||
| 2021-05-25 | Mann Paul Elliot Director | Grant or award · Stock Option (right to buy) | +49,084 | 49,084 | ||
| 2021-05-25 | Wider Todd Director | Grant or award | +38,590 | 63,590 | ||
| 2021-05-25 | Wider Todd Director | Grant or award · Stock Option (right to buy) | +49,084 | 49,084 | ||
| 2021-05-25 | Charles Faith L. Director | Grant or award | +77,181 | 77,181 | ||
| 2021-05-25 | Charles Faith L. Director | Grant or award · Stock Option (right to buy) | +98,168 | 98,168 | ||
| 2021-05-25 | Silverstein Christine Berni Director | Grant or award | +38,590 | 118,590 | ||
| 2021-05-25 | Silverstein Christine Berni Director | Grant or award · Stock Option (right to buy) | +49,084 | 49,084 | ||
| 2021-05-25 | Alvino Mark Director | Grant or award | +77,181 | 82,181 | ||
| 2021-05-25 | Alvino Mark Director | Grant or award · Stock Option (right to buy) | +98,168 | 98,168 | ||
| 2021-05-25 | Rouhandeh Steven H Director | Grant or award | +38,590 | 533,590 | ||
| 2021-05-25 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +49,084 | 49,084 | ||
| 2021-05-25 | Alland Leila Director | Grant or award | +77,181 | 77,181 | ||
| 2021-05-25 | Alland Leila Director | Grant or award · Stock Option (right to buy) | +98,168 | 98,168 | ||
| 2021-05-03 | SCO CAPITAL PARTNERS LLC Director | Sale | −80,000 | $2.01 | $161K | 11,079,292 |
Page 11 of 12 · 223 trades